logo

For the Inventor, By the Inventor

Emad S Alnemri

Ambler, PA, United States of America

Emad S Alnemri

LinkedIn

This inventor holds 34 USPTO granted patents, plus 1 CIPO patent, primarily in Apoptotic Proteases. Top assignees: Thomas Jefferson University, Idun Pharmaceuticals, Inc., Other. Active years: 1997-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emad S Alnemri. Retrieved from https://idiyas.com/inventor/emad-s-alnemri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34

% Patents Active = 97.1


Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 91(Granted Patents)


Location History:

  • Township Upper Dublin, County Montgomery, PA (US) (2002)
  • Upper Dublin Township, Montgomery County, PA (US) (2001 - 2003)
  • Ambler, PA (US) (1997 - 2005)

Company Filing History:

goldMedal27 out of 538 
 
Thomas Jefferson University
 patents
silverMedal3 out of 33 
 
Idun Pharmaceuticals, Inc.
 patents
bronzeMedal5 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1997-2005

Loading Chart...
Loading Chart...
Areas of Expertise:
Apoptotic Protease
Caspase-14
Mch2
Mch3
Mch4
Mch5
Mch6
FADD-like Molecules
Antibodies
Nucleic Acids
Blk Genes
Recombinant Caspases
34 patents (USPTO):Explore Patents
1. 6897296 - Antibody that specifically binds an Mch5 polypeptide (2005-05-24),
2. 6797812 - Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use (2004-09-28),
3. 6730779 - Antibody that specifically binds an Mch4 polypeptide (2004-05-04),
4. 6716960 - Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use (2004-04-06),
5. 6686459 - Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use (2004-02-03),
6. 6610541 - Recombinant, active caspases and uses thereof (2003-08-26),
7. 6600024 - Blk genes, gene products and uses thereof in apoptosis (2003-07-29),
8. 6576751 - FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same (2003-06-10),
9. 6566505 - Antibodies to Mch6 polypeptides (2003-05-20),
10. 6462175 - Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use (2002-10-08),
11. 6455296 - Apoptotic protease Mch6, nucleic acids encoding same and methods of use (2002-09-24),
12. 6432628 - Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use (2002-08-13),
13. 6417328 - Trail receptors, nucleic acids encoding the same, and methods of use thereof (2002-07-09),
14. 6407215 - Antibodies to Mch2, an apoptotic cysteine protease (2002-06-18),
15. 6403765 - Truncated Apaf-1 and methods of use thereof (2002-06-11),

Title: Emad S Alnemri: Pioneering Innovations in Biotechnology

Introduction:

Emad S Alnemri, a distinguished inventor based in Ambler, PA, has solidified his position as a trailblazer in the world of inventions. With a staggering 34 patents to his name, Alnemri's passion for innovation and dedication to excellence continue to shape the landscape of patents and innovations worldwide.

Latest Patents:

Among his latest patents is the groundbreaking invention of an Antibody that specifically binds an Mch5 polypeptide. This invention provides an isolated gene encoding Mch4 or Mch5, along with functional fragments thereof, opening new avenues in the field of biotechnology. Additionally, his work on Caspase-14, an apoptotic protease, has led to significant advancements. The isolated nucleic acid molecules encoding caspase-14 polypeptide or functional fragments thereof have paved the way for innovative research and development in the realm of biomedical sciences.

Career Highlights:

Emad S Alnemri's illustrious career includes collaborations with prestigious institutions such as Thomas Jefferson University, where his innovative spirit has been nurtured and thrived. His relentless pursuit of excellence has garnered him recognition as a leading authority in biotechnology and pharmaceutical research. Alnemri's contributions have not only advanced the field but have also inspired future generations of inventors and researchers to strive for excellence.

Collaborations:

Throughout his career, Alnemri has collaborated with esteemed professionals in the field, including Gerald Litwack and Teresa Fernandes-Alnemri. These fruitful collaborations have led to the development of cutting-edge technologies and breakthrough inventions, further solidifying his reputation as a visionary inventor.

Conclusion:

In conclusion, Emad S Alnemri's unwavering dedication to innovation and his remarkable contributions to the field of patents and inventions have cemented his legacy as a prominent figure in the world of biotechnology. His pioneering work continues to inspire and shape the future of innovation, setting new benchmarks for excellence in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…